Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

• Published in: The New England journal of medicine Vol. 384; no. 14; pp. 1372 - 1374
• Main Authors: Krammer, Florian, Srivastava, Komal, Alshammary, Hala, Amoako, Angela A., Awawda, Mahmoud H., Beach, Katherine F., Bermúdez-González, Maria C., Bielak, Dominika A., Carreño, Juan M., Chernet, Rachel L., Eaker, Lily Q., Ferreri, Emily D., Floda, Daniel L., Gleason, Charles R., Hamburger, Joshua Z., Jiang, Kaijun, Kleiner, Giulio, Jurczyszak, Denise, Matthews, Julia C., Mendez, Wanni A., Nabeel, Ismail, Mulder, Lubbertus C.F., Raskin, Ariel J., Russo, Kayla T., Salimbangon, Ashley-Beathrese T., Saksena, Miti, Shin, Amber S., Singh, Gagandeep, Sominsky, Levy A., Stadlbauer, Daniel, Wajnberg, Ania, Simon, Viviana
• Format: Journal Article
• Language: English
• Published: United States Massachusetts Medical Society 08.04.2021
• Subjects: Adult; Aged; Antibodies, Neutralizing - blood; Antibodies, Viral - blood; Area Under Curve; Correspondence; COVID-19 - immunology; COVID-19 - prevention & control; COVID-19 Vaccines - adverse effects; COVID-19 Vaccines - immunology; Female; Humans; Immunogenetic Phenomena; Immunoglobulin G - blood; Male; Middle Aged; SARS-CoV-2 - immunology; Spike Glycoprotein, Coronavirus - immunology
• ISSN: 0028-4793; 1533-4406; 1533-4406
• DOI: 10.1056/NEJMc2101667